Fiche publication
Date publication
août 2018
Journal
ACS applied materials & interfaces
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FOURNEL Sylvie
,
Dr FRISCH Benoit
,
Dr LAVALLE Philippe
,
Pr SCHAAF Pierre
Tous les auteurs :
Hardy A, Seguin C, Brion A, Lavalle P, Schaaf P, Fournel S, Bourel-Bonnet L, Frisch B, De Giorgi DM
Lien Pubmed
Résumé
Nowadays, the need for therapeutic biomaterials displaying anti-inflammatory properties to fight against inflammation-related diseases is continuously increasing. Compact PolyElectrolyte Complexes (CoPECs) represent a new class of materials obtained by ultracentrifugation of a polyanion/polycation complexes suspension in the presence of salt. Here, a non-cytotoxic β-cyclodextrin-functionalized chitosan/alginate CoPEC was formulated, characterized and described as a promising drug carrier displaying an intrinsic anti-inflammatory property. This new material was successfully formed and due to the presence of cyclodextrins, it was able to trap and release hydrophobic drugs such as Piroxicam used as model drug. The intrinsic anti-inflammatory activity of this CoPEC was analyzed in vitro using murine macrophages in the presence of LipoPolySaccharide (LPS) endotoxin. In this model, it was shown that CoPEC inhibited LPS-induced TNF-α and NO release and moderated the differentiation of LPS-activated macrophages. Over time, this kind of bioactive biomaterial could constitute a new family of delivery systems and expand the list of therapeutic tools available to target inflammatory chronic diseases such as arthritis or Crohn's disease.
Mots clés
CoPECs, alginate, anti-inflammatory, chitosan, cyclodextrins, drug carriers, natural biomaterials
Référence
ACS Appl Mater Interfaces. 2018 Aug 14;: